Essential thrombocythemia
A Tefferi, A Pardanani - New England Journal of Medicine, 2019 - Mass Medical Soc
Key Clinical Points Essential Thrombocythemia Essential thrombocythemia is associated
with an increased risk of thrombosis and bleeding. Most patients with essential …
with an increased risk of thrombosis and bleeding. Most patients with essential …
3023 Mayo Clinic patients with myeloproliferative neoplasms: risk-stratified comparison of survival and outcomes data among disease subgroups
N Szuber, M Mudireddy, M Nicolosi, D Penna… - Mayo Clinic …, 2019 - Elsevier
Abstract Objective To document the Mayo Clinic decades-long experience with
myeloproliferative neoplasms (MPNs) and provide mature risk-stratified survival data and …
myeloproliferative neoplasms (MPNs) and provide mature risk-stratified survival data and …
Primary myelofibrosis: spectrum of imaging features and disease-related complications
Primary myelofibrosis is a chronic clonal stem cell disorder that results in a build-up of
marrow fibrosis and dysfunction, hypermetabolic states, and myeloid metaplasia. The …
marrow fibrosis and dysfunction, hypermetabolic states, and myeloid metaplasia. The …
Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis
The aim of this study is to compare clinical outcomes of patients who underwent allogeneic
stem cell transplantation (HCT) for myelofibrosis with reduced intensity conditioning (RIC) …
stem cell transplantation (HCT) for myelofibrosis with reduced intensity conditioning (RIC) …
Allogeneic stem cell transplantation for myelofibrosis patients aged≥ 65 years
G Daghia, T Zabelina, G Zeck… - European Journal of …, 2019 - Wiley Online Library
Introduction Myelofibrosis (MF) is a disease of elderly with median age of 65 years at
diagnosis. Allogeneic stem cell transplantation (ASCT) currently is the only potentially …
diagnosis. Allogeneic stem cell transplantation (ASCT) currently is the only potentially …
[HTML][HTML] Overview of the mutational landscape in primary myelofibrosis and advances in novel therapeutics
Primary Myelofibrosis is a BCR-ABL negative myeloproliferative neoplasm with a variety of
hematological presentations, including thrombosis, bleeding diathesis and marrow fibrosis …
hematological presentations, including thrombosis, bleeding diathesis and marrow fibrosis …
Emerging drugs for essential thrombocythemia
L Masarova, S Verstovsek - Expert Opinion on Emerging Drugs, 2019 - Taylor & Francis
Introduction: Despite our recent progress in the understanding of essential thrombocythemia
(ET) pathogenesis, the therapeutic management of this disease has remained largely …
(ET) pathogenesis, the therapeutic management of this disease has remained largely …
A 12-year retrospective study of myeloproliferative neoplasm patients at Thammasat Hospital
H Prapitpaiboon, N Kanitsap - Thammasat Medical Journal, 2019 - he02.tci-thaijo.org
Background: Myeloproliferative neoplasm (MPN) are group of malignant hematologic
diseases related to abnormal hematopoietic stem cell, including chronic myeloid leukemia …
diseases related to abnormal hematopoietic stem cell, including chronic myeloid leukemia …
Thiol–Disulphide Homeostasis in Polycythemia Vera
AŞ Yıkılmaz, ŞM Bakanay, S Akinci, S Maral… - Dicle Tıp …, 2019 - dergipark.org.tr
Background: Thiol-disulphide homeostasis has vital role in cell signalling mechanisms,
regulation of transcription factors and enzymatic activities, signal transduction and regulation …
regulation of transcription factors and enzymatic activities, signal transduction and regulation …